CM
TGTX icon

Caption Management’s TG Therapeutics TGTX Stock Holding History

Caption Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.66M Sell
50,000
-10,000
-17% -$298K 0.01% 874
2025
Q4 		$1.79M Sell
60,000
-17,100
-22% -$558K 0.01% 873
2025
Q3 		$2.79M Buy
77,100
+45,600
+145% +$1.5M 0.02% 714
2025
Q2 		$1.13M Buy
31,500
+20,800
+194% +$774K 0.01% 897
2025
Q1 		$422K Sell
10,700
-112,500
-91% -$3.79M ﹤0.01% 1144
2024
Q4 		$3.71M Buy
123,200
+93,200
+311% +$2.67M 0.04% 471
2024
Q3 		$702K Buy
+30,000
New +$655K 0.01% 866
2024
Q2 		– Sell
-23,200
Closed -$353K – 1494
2024
Q1 		$353K Sell
23,200
-263,600
-92% -$4.2M 0.01% 928
2023
Q4 		$4.9M Buy
286,800
+109,800
+62% +$1.28M 0.07% 345
2023
Q3 		$1.48M Sell
177,000
-302,900
-63% -$4.22M 0.02% 661
2023
Q2 		$11.9M Buy
479,900
+273,800
+133% +$7.07M 0.21% 120
2023
Q1 		$3.1M Sell
206,100
-1,149,900
-85% -$17.5M 0.06% 335
2022
Q4 		$16M Buy
1,356,000
+1,214,300
+857% +$8.81M 0.25% 96
2022
Q3 		$838K Sell
141,700
-465,000
-77% -$3.05M 0.01% 922
2022
Q2 		$2.58M Buy
606,700
+425,100
+234% +$2.65M 0.04% 589
2022
Q1 		$1.73M Buy
+181,600
New +$2.1M 0.02% 802
2021
Q4 		– Sell
-45,000
Closed -$1.5M – 1922
2021
Q3 		$1.5M Sell
45,000
-55,000
-55% -$1.7M 0.02% 884
2021
Q2 		$3.88M Buy
+100,000
New +$3.93M 0.05% 439
2020
Q2 		– Sell
-370,900
Closed -$3.65M – 1175
2020
Q1 		$3.65M Buy
370,900
+69,200
+23% +$874K 0.21% 141
2019
Q4 		$3.35M Buy
+301,700
New +$2.29M 0.11% 250
2019
Q3 		– Sell
-149,000
Closed -$1.29M – 885
2019
Q2 		$1.29M Buy
+149,000
New +$1.13M 0.06% 327
2018
Q4 		– Sell
-174,900
Closed -$979K – 617
2018
Q3 		$979K Buy
+174,900
New +$2M 0.05% 343

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Caption Management's TGTX Position: Q4 2025 in Review

Caption Management sold out of TG Therapeutics (TGTX) in Q4 2025, closing a stake of 50,276 shares — an estimated $1.64M sold.

Caption Management first reported a position in TGTX in Q3 2018 and held it in 11 quarters. The position peaked at $12.2M in Q4 2021. 351 funds tracked by Wall St. Rank hold TGTX as of Q4 2025.

  • Caption Management reported no remaining TG Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Caption Management sold 50,276 TG Therapeutics shares in Q4 2025, an estimated $1.64M.
  • Caption Management first reported a position in TG Therapeutics in Q3 2018 and held it in 11 quarters.
  • Caption Management's TG Therapeutics position peaked at $12.2M in Q4 2021.
  • 351 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.